Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients.
A W MaoH BarckJ YoungA PaleyJian-Hua MaoH ChangPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
MAPS was successfully established to have independent prognostic value, and our study provides a new avenue for developing prognostic biomarkers by microbiome profiling.